81 related articles for article (PubMed ID: 7853701)
1. [Apolipoprotein (a)].
Okubo M
Nihon Rinsho; 1994 Dec; 52(12):3133-8. PubMed ID: 7853701
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) as a risk factor for atherosclerosis and thrombosis: mechanistic insights from animal models.
Boffa MB; Marcovina SM; Koschinsky ML
Clin Biochem; 2004 May; 37(5):333-43. PubMed ID: 15087247
[TBL] [Abstract][Full Text] [Related]
3. The identification of polymorphisms in the coding region of the apolipoprotein (a) gene--association with earlier identified polymorphic sites and influence on the lipoprotein (a) concentration.
Prins J; Leus FR; Bouma BN; van Rijn HJ
Thromb Haemost; 1999 Dec; 82(6):1709-17. PubMed ID: 10613659
[TBL] [Abstract][Full Text] [Related]
4. Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5'-flanking region.
Suzuki K; Kuriyama M; Saito T; Ichinose A
J Clin Invest; 1997 Mar; 99(6):1361-6. PubMed ID: 9077546
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning of the cDNA encoding the carboxy-terminal domain of chimpanzee apolipoprotein(a): an Asp57 --> Asn mutation in kringle IV-10 is associated with poor fibrin binding.
Chenivesse X; Huby T; Wickins J; Chapman J; Thillet J
Biochemistry; 1998 May; 37(20):7213-23. PubMed ID: 9585533
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein(a), atherosclerosis, and apolipoprotein(a) gene polymorphism.
Pati U; Pati N
Mol Genet Metab; 2000; 71(1-2):87-92. PubMed ID: 11001801
[TBL] [Abstract][Full Text] [Related]
7. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis.
Lackner C; Boerwinkle E; Leffert CC; Rahmig T; Hobbs HH
J Clin Invest; 1991 Jun; 87(6):2153-61. PubMed ID: 1645755
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the expression of the apolipoprotein(a) gene: evidence for a regulatory role of the 5' distal apolipoprotein(a) transcription control region enhancer in yeast artificial chromosome transgenic mice.
Huby T; Afzal V; Doucet C; Lawn RM; Gong EL; Chapman MJ; Thillet J; Rubin EM
Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1633-9. PubMed ID: 12842837
[TBL] [Abstract][Full Text] [Related]
9. Analysis of polymorphisms in the 5'-flanking region of the apolipoprotein(a) [Apo(a)] gene in Thai subjects with coronary artery diseases.
Tirawanchai N; Leowattana W; Somkasetrin A; Thongsaen P
J Med Assoc Thai; 2008 Jan; 91(1):86-92. PubMed ID: 18386550
[TBL] [Abstract][Full Text] [Related]
10. A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a).
Parson W; Kraft HG; Niederstätter H; Lingenhel AW; Köchl S; Fresser F; Utermann G
Hum Mutat; 2004 Dec; 24(6):474-80. PubMed ID: 15523644
[TBL] [Abstract][Full Text] [Related]
11. The identification and significance of a Thr-->Pro polymorphism in kringle IV type 8 of apolipoprotein(a).
Prins J; Leus FR; van der Hoek YY; Kastelein JJ; Bouma BN; van Rijn HJ
Thromb Haemost; 1997 May; 77(5):949-54. PubMed ID: 9184408
[TBL] [Abstract][Full Text] [Related]
12. The apolipoprotein(a) kringle IV repeats which differ from the major repeat kringle are present in variably-sized isoforms.
van der Hoek YY; Wittekoek ME; Beisiegel U; Kastelein JJ; Koschinsky ML
Hum Mol Genet; 1993 Apr; 2(4):361-6. PubMed ID: 8389224
[TBL] [Abstract][Full Text] [Related]
13. [Relation of pentanucleotide repeat polymorphism of apolipoprotein (a) gene to plasma lipoprotein (a) level among Chinese patients with myocardial infarction and cerebral infarction].
Liu X; Sun L; Li Z; Gao Y; Hui R
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1396-400. PubMed ID: 12509922
[TBL] [Abstract][Full Text] [Related]
14. Atherogenesis in transgenic mice expressing human apolipoprotein(a).
Lawn RM; Wade DP; Hammer RE; Chiesa G; Verstuyft JG; Rubin EM
Nature; 1992 Dec; 360(6405):670-2. PubMed ID: 1465128
[TBL] [Abstract][Full Text] [Related]
15. [Molecular patho-biochemistry and genetic diagnosis for plasminogen-apolipoprotein (a) gene family related to atherosclerosis and thrombosis].
Ichinose A
Rinsho Byori; 1998 Dec; 46(12):1210-8. PubMed ID: 9916506
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotide directed to human apolipoprotein B-100 reduces lipoprotein(a) levels and oxidized phospholipids on human apolipoprotein B-100 particles in lipoprotein(a) transgenic mice.
Merki E; Graham MJ; Mullick AE; Miller ER; Crooke RM; Pitas RE; Witztum JL; Tsimikas S
Circulation; 2008 Aug; 118(7):743-53. PubMed ID: 18663084
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of the atherogenic Lp(a) are elevated in FH.
Lingenhel A; Kraft HG; Kotze M; Peeters AV; Kronenberg F; Kruse R; Utermann G
Eur J Hum Genet; 1998 Jan; 6(1):50-60. PubMed ID: 9781014
[TBL] [Abstract][Full Text] [Related]
18. Identification of sequences in apolipoprotein(a) that maintain its closed conformation: a novel role for apo(a) isoform size in determining the efficiency of covalent Lp(a) formation.
Becker L; Cook PM; Koschinsky ML
Biochemistry; 2004 Aug; 43(31):9978-88. PubMed ID: 15287725
[TBL] [Abstract][Full Text] [Related]
19. Genetics and metabolism of lipoprotein(a) and their clinical implications (Part 1).
Dieplinger H; Kronenberg F
Wien Klin Wochenschr; 1999 Jan; 111(1):5-20. PubMed ID: 10067265
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
